Raymond James Financial »

Outlook Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.6k 27k 0.21
2025-06-30 $4.6k 2.9k 1.60

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Outlook Therapeutics

Armistice Capital
Vanguard Capital Management
Gilpin Wealth Management
Geode Capital Management
BlackRock
Warberg Asset Management
Renaissance Technologies
Connective Capital Management
Citadel Advisors
Susquehanna International
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
Simplex Trading
Group One Trading

View all funds holding Outlook Therapeutics